Phoenix Financial’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-48,716
| Closed | -$60.4K | – | 310 |
|
|
2022
Q4 | $60.4K | Buy |
48,716
+1,129
| +2% | +$1.4K | ﹤0.01% | 266 |
|
|
2022
Q3 | $55K | Sell |
47,587
-130,249
| -73% | -$151K | ﹤0.01% | 317 |
|
|
2022
Q2 | $282K | Buy |
177,836
+66,291
| +59% | +$105K | 0.01% | 314 |
|
|
2022
Q1 | $172K | Sell |
111,545
-12,321
| -10% | -$19K | ﹤0.01% | 384 |
|
|
2021
Q4 | $306K | Buy |
+123,866
| New | +$306K | 0.01% | 322 |
|